BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6219580)

  • 1. Therapy of malignancy-associated hypercalcemia: 1983.
    Stewart AF
    Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of hypercalcemia of malignancy.
    Singer FR; Fernandez M
    Am J Med; 1987 Feb; 82(2A):34-41. PubMed ID: 3826096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tumoral hypercalcemia: physiopathology and treatment].
    Rizzoli R; Jung A; Bonjour JP
    Schweiz Med Wochenschr; 1985 Mar; 115(10):326-32. PubMed ID: 3157214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
    Rosol TJ; Capen CC
    J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
    Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
    Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia of malignancy: diagnosis and therapy.
    Fetchick DA; Mundy GR
    Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical management of the hypercalcemia of malignancy.
    Deftos LJ; Neer R
    Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furosemide, mithramycin, and salmon calcitonin in hypercalcemia.
    Filastre JP; Humbert G; Leroy J; Maitrot J; Deshayes P; Canonne MA
    Eur J Intensive Care Med; 1975 Dec; 1(4):185-8. PubMed ID: 130239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
    Tai N; Inoue D
    Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
    Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE
    Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
    Siris ES; Hyman GA; Canfield RE
    Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of available medical therapy for hypercalcemia of malignancy.
    Mundy GR; Wilkinson R; Heath DA
    Am J Med; 1983 Mar; 74(3):421-32. PubMed ID: 6219578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride.
    Harinck HI; Bijvoet OL; Plantingh AS; Body JJ; Elte JW; Sleeboom HP; Wildiers J; Neijt JP
    Am J Med; 1987 Jun; 82(6):1133-42. PubMed ID: 3300303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilization hypercalcemia: a case report and review of the literature.
    Wolf AW; Chuinard RG; Riggins RS; Walter RM; Depner T
    Clin Orthop Relat Res; 1976; (118):124-9. PubMed ID: 133782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy of hypercalcemia due to malignancy.
    Raue F; Pecherstorfer M
    Recent Results Cancer Res; 1994; 137():138-60. PubMed ID: 7878293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.